Real Time Genomics Launches Two New Products in Human Disease Research

Real Time Genomics, Inc., the genome analytics company, today announced the commercial introduction of its rtgSingleton™ product for the genomic analysis of individual samples, and the Beta release of its rtgPopulation™ product for case-control and cohort applications. The singleton product is designed to analyze panels, exomes or genomes on a case-by-case basis. The population product [...]

ATCC Announces Creation of Biomaterial Contributor Network

ATCC, the premier global biological materials resource and standards organization, announces material deposit agreements with over 30 leading public and private institutions. These institutions will have the option to participate in the new Biomaterial Contributor Network (BCN), and make important research materials available to the research community. ATCC will coordinate with Technology Transfer Offices at [...]

Alan Faichney joins the Board of Arrayjet as Non-Executive Chairman

We're pleased to announce that Alan Faichney has joined the Board of Arrayjet as Non-Executive Chairman with immediate effect. Alan has 33 years of commercial and company leadership experience, building international businesses in the Technology sector. Beginning his career in the Aerospace industry, Alan later joined the oil exploration industry where he held key technical [...]

Agilent Technologies Launches Unique X-ray Detectors with Smart Sensitivity Control

SANTA CLARA, Calif., -- Agilent Technologies Inc. (NYSE: A) today launched a range of unique X-ray Diffraction CCD Detectors with Smart Sensitivity Control. The Eos S2, Atlas S2 and Titan S2 CCD detectors offer active areas of 92 mm, 135 mm and 165 mm, respectively, and automatically adapt their sensitivity based on the strength of [...]

ZEISS Crossbeam Sets New Standards in 3D Nanotomography and Nanofabrication

ZEISS will be presenting the first system of the new Crossbeam series at the MC 2013 in Regensburg, Germany. Its outstanding features include high speed in materials analysis and processing and its wide diversity of applications. Time intensive 3D experiments that used to run for several days can now be completed overnight. The newly developed [...]

Thermo Fisher Scientific Releases Next-Generation Benchtop NMR Spectrometer

MADISON, Wis., –– Academic and industrial laboratories can now easily collect routine high-resolution nuclear magnetic resonance (NMR) data on molecules in solution using the Thermo Scientific picoSpin 80, a portable, competitively-priced NMR spectrometer built for benchtop operation. The instrument’s magnet, rated at 2 Tesla, is designed to provide superior resolution of chemical and structural characteristics [...]

Partners HealthCare Launches Service to Offer Patients Clinical Whole Genome Sequencing and Interpretation

BOSTON, MA - Partners HealthCare today announced that it has started offering doctors and patients the option of whole genome sequencing, analysis and interpretation. The test, available to patients across the nation, will offer physicians and patients the ability to better diagnose and treat disease. Partners is the one of the first health care systems [...]

NEW Low Cost Mini Peristaltic Pump

AALBORG® Instruments is pleased to announce the introduction of the Model TPT low cost / low flow mini peristaltic pumps. These New models feature Flow Rates from 1 ml/min up to 30 ml/min by selecting from a choice of 4 different RPM drives (8, 12, 17 or 25 RPM) and a choice of tubing sizes. [...]

2D Code Reader Offers Unmatched Data Integrity

Micronic has announced the launch of the new Tracxer Code Reader TS201 - an attractively designed product for reading the 2D Data-Matrix codes of single 24-, 48- and 96-well format sample storage tubes. Incorporating proprietary 'keyboard wedge' functionality the Tracxer Code Reader TS201 is able to automatically scan and decode any 2D Data-Matrix code making [...]

BD Supports the FDA’s Proposal to Reclassify Rapid Influenza Tests

Franklin Lakes, NJ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, supports the U.S. Food and Drug Administration’s (FDA’s) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA’s CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA’s proposal to reclassify rapid influenza detection [...]

Access IBO on Knowledge Center